Table 2 Distribution of people in each age group, with low, medium or high risk for pneumococcal diseases or their complications[21]
From: Cost-effectiveness analysis of pneumococcal conjugate vaccine 13-valent in older adults in Colombia
Age groups | Risk level | ||
|---|---|---|---|
Low | Medium | High | |
50 – 64 years | 52.2% | 36.6% | 11.2% |
65 – 74 years | 41.7% | 38.5% | 19.8% |
75 – 84 years | 37.4% | 36.9% | 25.7% |
85 – 99 years | 36.6% | 34.3% | 29.1% |